Related Experiment Video
Updated: Apr 17, 2026
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
High dose dexmedetomidine: effective as a sole agent sedation for children undergoing MRI
Sheikh Sohail Ahmed1, Tamara Unland2, James E Slaven3
1Department of Pediatrics, Section of Pediatric Critical Care, Pediatric Sedation and Cardiovascular Intensive Care Unit, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, 705 Riley Hospital Drive RI 4909 4B, Indianapolis, IN 46202, USA.
Abstract:
Objective. To determine the efficacy and safety of high dose dexmedetomidine as a sole sedative agent for MRI. We report our institution's experience. Design. A retrospective institutional review of dexmedetomidine usage for pediatric MRI over 5.5 years. Protocol included a dexmedetomidine bolus of 2 μg/kg intravenously over ten minutes followed by 1 μg/kg/hr infusion. 544 patients received high dose dexmedetomidine for MRI. A second bolus was used in 103 (18.9%) patients. 117 (21.5%) required additional medications. Efficacy, side effects, and use of additional medicines to complete the MRI were reviewed. Data was analyzed using Student's t-test, Fisher's exact test, and Analysis of Variance (ANOVA). Main Results. Dexmedetomidine infusion was associated with bradycardia (3.9%) and hypotension (18.4%). None of the patients required any intervention. Vital signs were not significantly different among the subgroup of patients receiving one or two boluses of dexmedetomidine or additional medications. Procedure time was significantly shorter in the group receiving only one dexmedetomidine bolus and increased with second bolus or additional medications (P < 0.0001). Discharge time was longer for children experiencing bradycardia (P = 0.0012). Conclusion. High dose Dexmedetomidine was effective in 78.5% of cases; 21.5% of patients required additional medications. Side effects occurred in approximately 25% of cases, resolving spontaneously.
Insights
High-dose dexmedetomidine is an effective sole sedative for pediatric MRI, with 78.5% of patients achieving sedation without additional medications. Side effects like bradycardia and hypotension were generally mild and self-resolving.
Area of Science:
- Anesthesiology
- Pediatric Imaging
- Pharmacology
Background:
- Sedation is crucial for pediatric MRI to ensure patient cooperation and image quality.
- Dexmedetomidine is a commonly used sedative, but its efficacy and safety as a sole agent at high doses for MRI require further evaluation.
Purpose of the Study:
- To assess the efficacy and safety of high-dose dexmedetomidine as a sole sedative agent for pediatric magnetic resonance imaging (MRI).
Main Methods:
- A retrospective review of 544 pediatric patients undergoing MRI with high-dose dexmedetomidine sedation.
- The protocol involved an initial bolus followed by continuous infusion, with analysis of efficacy, side effects, and need for additional medications.
- Statistical analysis included Student's t-test, Fisher's exact test, and ANOVA.
Main Results:
- High-dose dexmedetomidine was effective in 78.5% of cases, with 21.5% requiring additional medications.
- Adverse events included bradycardia (3.9%) and hypotension (18.4%), none requiring intervention.
- Procedure time was shorter with a single bolus and longer with additional medications or a second bolus.
Conclusions:
- High-dose dexmedetomidine is a safe and effective sole sedative for pediatric MRI.
- While side effects can occur, they are typically mild and resolve spontaneously.
- Optimizing the dexmedetomidine protocol may further improve procedural efficiency.
Related Concept Videos
01:14Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
01:21Imaging Studies for Cardiovascular System IV: CMRI
01:24Parenteral Anesthetics: Overview
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:24Magnetic Resonance Imaging
01:27Imaging Studies IV: Magnetic Resonance Imaging